BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 409938 CCn1c(=O)n(C2CCCC2)c2c3cccc(OC)c3ncc2c1=O InChI=1S/C19H21N3O3/c1-3-21-18(23)14-11-20-16-13(9-6-10-15(16)25-2)17(14)22(19(21)24)12-7-4-5-8-12/h6,9-12H,3-5,7-8H2,1-2H3 SHXAYINEIAIQRK-UHFFFAOYSA-N 235278 US10085990, Example 1::US9393245, 1 Tumor necrosis factor Homo sapiens 180 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235278&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010869 340095004 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409939 CCn1c(=O)n(-c2ccc(OC)c(OC)c2)c2c3cccc(OC)c3ncc2c1=O InChI=1S/C22H21N3O5/c1-5-24-21(26)15-12-23-19-14(7-6-8-17(19)29-3)20(15)25(22(24)27)13-9-10-16(28-2)18(11-13)30-4/h6-12H,5H2,1-4H3 HBWXXRCASVTUIK-UHFFFAOYSA-N 235281 US10085990, Example 4::US9393245, 4 Tumor necrosis factor Homo sapiens 14200 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235281&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010870 340095005 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409940 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(C(C)C)c1=O InChI=1S/C20H23N3O3/c1-12(2)22-19(24)15-11-21-17-14(9-6-10-16(17)26-3)18(15)23(20(22)25)13-7-4-5-8-13/h6,9-13H,4-5,7-8H2,1-3H3 USNHXPAJBZXQCY-UHFFFAOYSA-N 235282 US10085990, Example 5::US9393245, 5 Tumor necrosis factor Homo sapiens 270 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235282&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762255 340095006 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409941 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cccs2)c1=O InChI=1S/C21H19N3O3S/c1-27-16-9-4-8-14-18(16)22-12-15-19(14)23(13-6-2-3-7-13)21(26)24(20(15)25)17-10-5-11-28-17/h4-5,8-13H,2-3,6-7H2,1H3 WEWXZCSTWDNTEE-UHFFFAOYSA-N 235287 US10085990, Example 10::US9393245, 10 Tumor necrosis factor Homo sapiens 410 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235287&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010871 340095007 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409942 CCCn1c2c3cccc(OC)c3ncc2c(=O)n(CC)c1=O InChI=1S/C17H19N3O3/c1-4-9-20-15-11-7-6-8-13(23-3)14(11)18-10-12(15)16(21)19(5-2)17(20)22/h6-8,10H,4-5,9H2,1-3H3 UUMJILIRWRRMQI-UHFFFAOYSA-N 235293 US10085990, Example 16::US9393245, 16 Tumor necrosis factor Homo sapiens 680 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235293&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010872 340095008 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409943 CCCCn1c2c3cccc(OC)c3ncc2c(=O)n(CC)c1=O InChI=1S/C18H21N3O3/c1-4-6-10-21-16-12-8-7-9-14(24-3)15(12)19-11-13(16)17(22)20(5-2)18(21)23/h7-9,11H,4-6,10H2,1-3H3 MYTFCNPKIZVZPE-UHFFFAOYSA-N 235294 US10085990, Example 17::US9393245, 17 Tumor necrosis factor Homo sapiens 390 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235294 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235294&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010873 340095009 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409944 CCn1c(=O)n(CC(C)C)c2c3cccc(OC)c3ncc2c1=O InChI=1S/C18H21N3O3/c1-5-20-17(22)13-9-19-15-12(7-6-8-14(15)24-4)16(13)21(18(20)23)10-11(2)3/h6-9,11H,5,10H2,1-4H3 DSQGVLPQTIMWFJ-UHFFFAOYSA-N 235295 US10085990, Example 18::US9393245, 18 Tumor necrosis factor Homo sapiens 1100 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235295&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010874 340095010 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409945 CCn1c(=O)n(C2CCCC2)c2c3cc(Cl)cc(OC)c3ncc2c1=O InChI=1S/C19H20ClN3O3/c1-3-22-18(24)14-10-21-16-13(8-11(20)9-15(16)26-2)17(14)23(19(22)25)12-6-4-5-7-12/h8-10,12H,3-7H2,1-2H3 SJDNWMAHIOSFDW-UHFFFAOYSA-N 235305 US10085990, Example 28::US9393245, 28 Tumor necrosis factor Homo sapiens 3500 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235305 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235305&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010875 340095011 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409946 CCn1c(=O)n(C2CCCC2)c2c3cc(F)cc(OC)c3ncc2c1=O InChI=1S/C19H20FN3O3/c1-3-22-18(24)14-10-21-16-13(8-11(20)9-15(16)26-2)17(14)23(19(22)25)12-6-4-5-7-12/h8-10,12H,3-7H2,1-2H3 JZFDIZGFYOAGNF-UHFFFAOYSA-N 235306 US10085990, Example 29::US9393245, 29 Tumor necrosis factor Homo sapiens 920 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235306 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235306&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010876 340095012 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409947 CCn1c(=O)n(C2CCCC2)c2c3cccc(Cl)c3ncc2c1=O InChI=1S/C18H18ClN3O2/c1-2-21-17(23)13-10-20-15-12(8-5-9-14(15)19)16(13)22(18(21)24)11-6-3-4-7-11/h5,8-11H,2-4,6-7H2,1H3 RNTPXDNXVJTNNP-UHFFFAOYSA-N 135812 US10085990, Example 30::US10568888, Example 30::US8853226, 30::US9393245, 30::US9833457, 30 Tumor necrosis factor Homo sapiens 2500 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135812 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135812&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762338 249493580 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409948 CCCc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(CC)c1=O InChI=1S/C21H25N3O2/c1-3-8-14-9-7-12-16-18(14)22-13-17-19(16)24(15-10-5-6-11-15)21(26)23(4-2)20(17)25/h7,9,12-13,15H,3-6,8,10-11H2,1-2H3 IAIFPELWEXGBKC-UHFFFAOYSA-N 135813 US10085990, Example 32::US10568888, Example 32::US8853226, 32::US9393245, 32::US9833457, 32 Tumor necrosis factor Homo sapiens 2600 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135813 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135813&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762254 249493581 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409949 CCn1c(=O)n(C2CCCC2)c2c3cccc(C(C)C)c3ncc2c1=O InChI=1S/C21H25N3O2/c1-4-23-20(25)17-12-22-18-15(13(2)3)10-7-11-16(18)19(17)24(21(23)26)14-8-5-6-9-14/h7,10-14H,4-6,8-9H2,1-3H3 IWWGJHDCEUWDTE-UHFFFAOYSA-N 135814 US10085990, Example 33::US10568888, Example 33::US8853226, 33::US9393245, 33::US9833457, 33 Tumor necrosis factor Homo sapiens 20000 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135814&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762293 249493582 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409950 CCn1c(=O)n(C2CCCC2)c2c3cccc(OC(F)(F)F)c3ncc2c1=O InChI=1S/C19H18F3N3O3/c1-2-24-17(26)13-10-23-15-12(8-5-9-14(15)28-19(20,21)22)16(13)25(18(24)27)11-6-3-4-7-11/h5,8-11H,2-4,6-7H2,1H3 LQKZFQQCAIABHJ-UHFFFAOYSA-N 235308 US10085990, Example 34::US9393245, 34 Tumor necrosis factor Homo sapiens 3600 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235308 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235308&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010877 340095013 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409951 CCn1c(=O)n(C(C)C)c2c3cccc(OC)c3ncc2c1=O InChI=1S/C17H19N3O3/c1-5-19-16(21)12-9-18-14-11(7-6-8-13(14)23-4)15(12)20(10(2)3)17(19)22/h6-10H,5H2,1-4H3 OCWUAPKGIXHEQM-UHFFFAOYSA-N 235311 US10085990, Example 37::US9393245, 37 Tumor necrosis factor Homo sapiens 20000 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235311 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235311&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010878 340095014 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409952 CCC(C)n1c(=O)n(C2CCCC2)c2c3cccc(OC)c3ncc2c1=O InChI=1S/C21H25N3O3/c1-4-13(2)23-20(25)16-12-22-18-15(10-7-11-17(18)27-3)19(16)24(21(23)26)14-8-5-6-9-14/h7,10-14H,4-6,8-9H2,1-3H3 NBFTZVSMVCSLPI-UHFFFAOYSA-N 235312 US10085990, Example 38::US9393245, 38 Tumor necrosis factor Homo sapiens 450 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235312 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235312&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010879 340095015 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409953 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2ccccc2)c1=O InChI=1S/C23H21N3O3/c1-29-19-13-7-12-17-20(19)24-14-18-21(17)25(15-10-5-6-11-15)23(28)26(22(18)27)16-8-3-2-4-9-16/h2-4,7-9,12-15H,5-6,10-11H2,1H3 RSCKXYMEBLRFKV-UHFFFAOYSA-N 235313 US10085990, Example 39::US9393245, 39 Tumor necrosis factor Homo sapiens 1300 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235313 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235313&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762265 340095016 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409954 CCn1c(=O)n(C2CCCC2)c2c3cccc(C)c3ncc2c1=O InChI=1S/C19H21N3O2/c1-3-21-18(23)15-11-20-16-12(2)7-6-10-14(16)17(15)22(19(21)24)13-8-4-5-9-13/h6-7,10-11,13H,3-5,8-9H2,1-2H3 UPWIYKDVUPWFNE-UHFFFAOYSA-N 235315 US10085990, Example 41::US9393245, 41 Tumor necrosis factor Homo sapiens 500 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235315 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235315&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010880 340095017 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409955 CCn1c(=O)n(C2CCC(C)CC2)c2c3cccc(OC)c3ncc2c1=O InChI=1S/C21H25N3O3/c1-4-23-20(25)16-12-22-18-15(6-5-7-17(18)27-3)19(16)24(21(23)26)14-10-8-13(2)9-11-14/h5-7,12-14H,4,8-11H2,1-3H3 DLVHYSMNJZZBJZ-UHFFFAOYSA-N 235319 US10085990, Example 45::US9393245, 45 Tumor necrosis factor Homo sapiens 200 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235319 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235319&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010881 340095018 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409956 CCOC(=O)Cn1c(=O)n(C2CCCC2)c2c3cccc(OC)c3ncc2c1=O InChI=1S/C21H23N3O5/c1-3-29-17(25)12-23-20(26)15-11-22-18-14(9-6-10-16(18)28-2)19(15)24(21(23)27)13-7-4-5-8-13/h6,9-11,13H,3-5,7-8,12H2,1-2H3 QVFKSVSVSZNHBI-UHFFFAOYSA-N 235320 US10085990, Example 46::US9393245, 46 Tumor necrosis factor Homo sapiens 1000 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235320 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235320&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010882 340095019 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409957 CCn1c(=O)n(CCCF)c2c3cccc(OC)c3ncc2c1=O InChI=1S/C17H18FN3O3/c1-3-20-16(22)12-10-19-14-11(6-4-7-13(14)24-2)15(12)21(17(20)23)9-5-8-18/h4,6-7,10H,3,5,8-9H2,1-2H3 WIXFQAYAKRUUGT-UHFFFAOYSA-N 235321 US10085990, Example 47::US9393245, 47 Tumor necrosis factor Homo sapiens 900 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235321 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235321&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010883 340095020 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409958 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(C)c1=O InChI=1S/C18H19N3O3/c1-20-17(22)13-10-19-15-12(8-5-9-14(15)24-2)16(13)21(18(20)23)11-6-3-4-7-11/h5,8-11H,3-4,6-7H2,1-2H3 AIQDEWPLFZXAOT-UHFFFAOYSA-N 235322 US10085990, Example 48::US9393245, 48 Tumor necrosis factor Homo sapiens 1400 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235322 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235322&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010884 340095021 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409959 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cc(C)cs2)c1=O InChI=1S/C22H21N3O3S/c1-13-10-18(29-12-13)25-21(26)16-11-23-19-15(8-5-9-17(19)28-2)20(16)24(22(25)27)14-6-3-4-7-14/h5,8-12,14H,3-4,6-7H2,1-2H3 XBMCCMKXNQMPDO-UHFFFAOYSA-N 135815 US10085990, Example 51::US10568888, Example 51::US8853226, 51::US9393245, 51::US9833457, 51 Tumor necrosis factor Homo sapiens 30 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135815 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135815&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 91618205 249493583 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409960 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cccc(C)c2)c1=O InChI=1S/C24H23N3O3/c1-15-7-5-10-17(13-15)27-23(28)19-14-25-21-18(11-6-12-20(21)30-2)22(19)26(24(27)29)16-8-3-4-9-16/h5-7,10-14,16H,3-4,8-9H2,1-2H3 NMCBQDCTQPGXHQ-UHFFFAOYSA-N 135816 US10085990, Example 54::US10568888, Example 54::US8853226, 54::US9393245, 54::US9833457, 54 Tumor necrosis factor Homo sapiens 6 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135816 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135816&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762299 249493584 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409961 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2ccc(C)cc2)c1=O InChI=1S/C24H23N3O3/c1-15-10-12-17(13-11-15)27-23(28)19-14-25-21-18(8-5-9-20(21)30-2)22(19)26(24(27)29)16-6-3-4-7-16/h5,8-14,16H,3-4,6-7H2,1-2H3 FOCBXVWTIKRGEO-UHFFFAOYSA-N 235327 US10085990, Example 55::US9393245, 55 Tumor necrosis factor Homo sapiens 163 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235327 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235327&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762279 340095022 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409962 COc1cccc2c1ncc1c2n(C2CCC(C)CC2)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H24ClN3O3/c1-15-9-11-17(12-10-15)28-23-19-7-4-8-21(32-2)22(19)27-14-20(23)24(30)29(25(28)31)18-6-3-5-16(26)13-18/h3-8,13-15,17H,9-12H2,1-2H3 HMHMNSOEZLANDL-UHFFFAOYSA-N 235344 US10085990, Example 72::US9393245, 72 Tumor necrosis factor Homo sapiens 4 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235344 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235344&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762273 340095023 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409963 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C23H20ClN3O3/c1-30-19-11-5-10-17-20(19)25-13-18-21(17)26(15-7-2-3-8-15)23(29)27(22(18)28)16-9-4-6-14(24)12-16/h4-6,9-13,15H,2-3,7-8H2,1H3 JUZPJZSDHMNYSS-UHFFFAOYSA-N 235345 US10085990, Example 73::US9393245, 73 Tumor necrosis factor Homo sapiens 9 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235345 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235345&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762269 340095024 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409964 CCc1cccc(c1)-n1c(=O)n(C2CCCC2)c2c3cccc(OC)c3ncc2c1=O InChI=1S/C25H25N3O3/c1-3-16-8-6-11-18(14-16)28-24(29)20-15-26-22-19(12-7-13-21(22)31-2)23(20)27(25(28)30)17-9-4-5-10-17/h6-8,11-15,17H,3-5,9-10H2,1-2H3 PUVOZFSDIYNDGR-UHFFFAOYSA-N 235347 US10085990, Example 75::US9393245, 75 Tumor necrosis factor Homo sapiens 6 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235347 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235347&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010885 340095025 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409965 COc1cccc2c1ncc1c2n(C2CCC(C)CC2)c(=O)n(-c2cccc(C)c2)c1=O InChI=1S/C26H27N3O3/c1-16-10-12-18(13-11-16)28-24-20-8-5-9-22(32-3)23(20)27-15-21(24)25(30)29(26(28)31)19-7-4-6-17(2)14-19/h4-9,14-16,18H,10-13H2,1-3H3 RUKDKMBIZSFODD-UHFFFAOYSA-N 235350 US10085990, Example 78::US9393245, 78 Tumor necrosis factor Homo sapiens 1 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235350 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235350&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762242 340095026 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409966 CCCCn1c2c3cccc(OC)c3ncc2c(=O)n(-c2cccc(C)c2)c1=O InChI=1S/C23H23N3O3/c1-4-5-12-25-21-17-10-7-11-19(29-3)20(17)24-14-18(21)22(27)26(23(25)28)16-9-6-8-15(2)13-16/h6-11,13-14H,4-5,12H2,1-3H3 QEHLDAILVPJKJD-UHFFFAOYSA-N 235355 US10085990, Example 83::US9393245, 83 Tumor necrosis factor Homo sapiens 1 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235355&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762291 340095027 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409967 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2ccc3OCOc3c2)c1=O InChI=1S/C24H21N3O5/c1-30-19-8-4-7-16-21(19)25-12-17-22(16)26(14-5-2-3-6-14)24(29)27(23(17)28)15-9-10-18-20(11-15)32-13-31-18/h4,7-12,14H,2-3,5-6,13H2,1H3 JMKXHWHMULJLQG-UHFFFAOYSA-N 135817 US10085990, Example 84::US10568888, Example 84::US8853226, 84::US9393245, 84::US9833457, 84 Tumor necrosis factor Homo sapiens 2 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135817 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135817&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 74944884 249493585 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409968 COc1cccc2c1ncc1c2n(C2CCC(F)(F)CC2)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C24H20ClF2N3O3/c1-33-19-7-3-6-17-20(19)28-13-18-21(17)29(15-8-10-24(26,27)11-9-15)23(32)30(22(18)31)16-5-2-4-14(25)12-16/h2-7,12-13,15H,8-11H2,1H3 JUOMAZJAWFVNCD-UHFFFAOYSA-N 235358 US10085990, Example 87::US9393245, 87 Tumor necrosis factor Homo sapiens 2 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235358 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235358&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762290 340095028 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409969 COc1cccc2c1ncc1c2n(C2CCN(CC2)C(=O)OC(C)(C)C)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C28H29ClN4O5/c1-28(2,3)38-27(36)31-13-11-18(12-14-31)32-24-20-9-6-10-22(37-4)23(20)30-16-21(24)25(34)33(26(32)35)19-8-5-7-17(29)15-19/h5-10,15-16,18H,11-14H2,1-4H3 WLPGFXATLLKQGT-UHFFFAOYSA-N 235359 US10085990, Example 88::US9393245, 88 Tumor necrosis factor Homo sapiens 1 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235359 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235359&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 74944886 340095029 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409970 COc1cccc2c1ncc1c2n(C2CCNCC2)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C23H21ClN4O3/c1-31-19-7-3-6-17-20(19)26-13-18-21(17)27(15-8-10-25-11-9-15)23(30)28(22(18)29)16-5-2-4-14(24)12-16/h2-7,12-13,15,25H,8-11H2,1H3 CZVSIRAXWOPYTM-UHFFFAOYSA-N 235360 US10085990, Example 89::US9393245, 89 Tumor necrosis factor Homo sapiens 5 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235360 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235360&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762296 340095030 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409971 COc1cccc2c1ncc1c2n(C2CCN(CC2)C(C)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H23ClN4O4/c1-15(31)28-11-9-17(10-12-28)29-23-19-7-4-8-21(34-2)22(19)27-14-20(23)24(32)30(25(29)33)18-6-3-5-16(26)13-18/h3-8,13-14,17H,9-12H2,1-2H3 LXSZIQSHGAAWFX-UHFFFAOYSA-N 235361 US10085990, Example 90::US9393245, 90 Tumor necrosis factor Homo sapiens 2 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235361 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235361&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762292 340095031 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409972 COc1cccc2c1ncc1c2n(C2CCN(CC2)C(=O)c2ccccc2)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C30H25ClN4O4/c1-39-25-12-6-11-23-26(25)32-18-24-27(23)34(30(38)35(29(24)37)22-10-5-9-20(31)17-22)21-13-15-33(16-14-21)28(36)19-7-3-2-4-8-19/h2-12,17-18,21H,13-16H2,1H3 DFTGKUJJDBYDBZ-UHFFFAOYSA-N 235362 US10085990, Example 91::US9393245, 91 Tumor necrosis factor Homo sapiens 1 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235362 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235362&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762238 340095032 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409973 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C24H23ClN4O5S/c1-34-20-8-4-7-18-21(20)26-14-19-22(18)28(16-9-11-27(12-10-16)35(2,32)33)24(31)29(23(19)30)17-6-3-5-15(25)13-17/h3-8,13-14,16H,9-12H2,1-2H3 MUQKVPSLHRVESB-UHFFFAOYSA-N 135818 US10085990, Example 92::US10568888, Example 92::US8853226, 92::US9393245, 92::US9833457, 92 Tumor necrosis factor Homo sapiens 2.4 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135818 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135818&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 74944887 249493586 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409974 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(=O)(=O)C(C)C)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C26H27ClN4O5S/c1-16(2)37(34,35)29-12-10-18(11-13-29)30-24-20-8-5-9-22(36-3)23(20)28-15-21(24)25(32)31(26(30)33)19-7-4-6-17(27)14-19/h4-9,14-16,18H,10-13H2,1-3H3 XUUYDWPUWOPVDD-UHFFFAOYSA-N 235363 US10085990, Example 93::US9393245, 93 Tumor necrosis factor Homo sapiens 0.4 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235363 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235363&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762317 340095033 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409975 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(=O)(=O)N(C)C)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H26ClN5O5S/c1-28(2)37(34,35)29-12-10-17(11-13-29)30-23-19-8-5-9-21(36-3)22(19)27-15-20(23)24(32)31(25(30)33)18-7-4-6-16(26)14-18/h4-9,14-15,17H,10-13H2,1-3H3 VBDPBRNLIHHGNF-UHFFFAOYSA-N 235364 US10085990, Example 94::US9393245, 94 Tumor necrosis factor Homo sapiens 0.4 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235364 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235364&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762277 340095034 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409976 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(=O)(=O)c2ccccc2)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C29H25ClN4O5S/c1-39-25-12-6-11-23-26(25)31-18-24-27(23)33(29(36)34(28(24)35)21-8-5-7-19(30)17-21)20-13-15-32(16-14-20)40(37,38)22-9-3-2-4-10-22/h2-12,17-18,20H,13-16H2,1H3 ZPBLUEXWDMMUHO-UHFFFAOYSA-N 235365 US10085990, Example 95::US9393245, 95 Tumor necrosis factor Homo sapiens 1 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235365 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235365&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762247 340095035 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409977 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(=O)(=O)C2CCS(=O)(=O)C2)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C27H27ClN4O7S2/c1-39-23-7-3-6-21-24(23)29-15-22-25(21)31(27(34)32(26(22)33)19-5-2-4-17(28)14-19)18-8-11-30(12-9-18)41(37,38)20-10-13-40(35,36)16-20/h2-7,14-15,18,20H,8-13,16H2,1H3 HYQJMZNWNFLLRO-UHFFFAOYSA-N 235366 US10085990, Example 96::US9393245, 96 Tumor necrosis factor Homo sapiens 0.4 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235366 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235366&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 74944948 340095036 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409978 CCNC(=O)N1CCC(CC1)n1c2c3cccc(OC)c3ncc2c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C26H26ClN5O4/c1-3-28-25(34)30-12-10-17(11-13-30)31-23-19-8-5-9-21(36-2)22(19)29-15-20(23)24(33)32(26(31)35)18-7-4-6-16(27)14-18/h4-9,14-15,17H,3,10-13H2,1-2H3,(H,28,34) RWLRTFPNLBUMPG-UHFFFAOYSA-N 235367 US10085990, Example 97::US9393245, 97 Tumor necrosis factor Homo sapiens 0.6 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235367 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235367&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762305 340095037 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409979 COc1cccc2c1ncc1c2n(C2CCN(CC2)C(=O)NC(C)C)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C27H28ClN5O4/c1-16(2)30-26(35)31-12-10-18(11-13-31)32-24-20-8-5-9-22(37-3)23(20)29-15-21(24)25(34)33(27(32)36)19-7-4-6-17(28)14-19/h4-9,14-16,18H,10-13H2,1-3H3,(H,30,35) IEYGNATYSGSBRX-UHFFFAOYSA-N 235368 US10085990, Example 98::US9393245, 98 Tumor necrosis factor Homo sapiens 0.3 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235368 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235368&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762267 340095038 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409980 COc1cccc2c1ncc1c2n(C2CCC(C)CC2)c(=O)n(-c2ccccc2Cl)c1=O InChI=1S/C25H24ClN3O3/c1-15-10-12-16(13-11-15)28-23-17-6-5-9-21(32-2)22(17)27-14-18(23)24(30)29(25(28)31)20-8-4-3-7-19(20)26/h3-9,14-16H,10-13H2,1-2H3 OIRXJBOZVQMRJB-UHFFFAOYSA-N 235369 US10085990, Example 99::US9393245, 99 Tumor necrosis factor Homo sapiens 20 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235369 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235369&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010886 340095039 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409981 COc1cccc2c1ncc1c2n(C2CCC(C)CC2)c(=O)n(-c2ccc(Cl)cc2)c1=O InChI=1S/C25H24ClN3O3/c1-15-6-10-17(11-7-15)28-23-19-4-3-5-21(32-2)22(19)27-14-20(23)24(30)29(25(28)31)18-12-8-16(26)9-13-18/h3-5,8-9,12-15,17H,6-7,10-11H2,1-2H3 ZRGJKRMJNFVOLW-UHFFFAOYSA-N 235370 US10085990, Example 100::US9393245, 100 Tumor necrosis factor Homo sapiens 0.9 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235370 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235370&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010887 340095040 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409982 COc1cccc2c1ncc1c2n(C2CC[C@@H](CC2)C(O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H22ClN3O5/c1-34-20-7-3-6-18-21(20)27-13-19-22(18)28(16-10-8-14(9-11-16)24(31)32)25(33)29(23(19)30)17-5-2-4-15(26)12-17/h2-7,12-14,16H,8-11H2,1H3,(H,31,32)/t14-,16? VLSIAPYZDCCBPU-GBANJREWSA-N 135819 US10085990, Example 103::US10568888, Example 103::US8853226, 103::US9393245, 103 Tumor necrosis factor Homo sapiens 1 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135819 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135819&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 74931538 249493587 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409983 COc1cccc2c1ncc1c2n(C2CCCCC2)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C24H22ClN3O3/c1-31-20-12-6-11-18-21(20)26-14-19-22(18)27(16-8-3-2-4-9-16)24(30)28(23(19)29)17-10-5-7-15(25)13-17/h5-7,10-14,16H,2-4,8-9H2,1H3 BOWZLOCTDYTWKK-UHFFFAOYSA-N 235374 US10085990, Example 106::US9393245, 106 Tumor necrosis factor Homo sapiens 4 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235374 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235374&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010888 340095041 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409984 COc1cccc2c1ncc1c2n(C2CCN(CC2)C(=O)OC(C)(C)C)c(=O)n(-c2ccc3OCOc3c2)c1=O InChI=1S/C29H30N4O7/c1-29(2,3)40-28(36)31-12-10-17(11-13-31)32-25-19-6-5-7-22(37-4)24(19)30-15-20(25)26(34)33(27(32)35)18-8-9-21-23(14-18)39-16-38-21/h5-9,14-15,17H,10-13,16H2,1-4H3 MYNFJASRUQCJTA-UHFFFAOYSA-N 235375 US10085990, Example 107::US9393245, 107 Tumor necrosis factor Homo sapiens 1 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235375 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235375&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010889 340095042 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409985 COc1cccc2c1ncc1c2n(C2CCNCC2)c(=O)n(-c2ccc3OCOc3c2)c1=O InChI=1S/C24H22N4O5/c1-31-19-4-2-3-16-21(19)26-12-17-22(16)27(14-7-9-25-10-8-14)24(30)28(23(17)29)15-5-6-18-20(11-15)33-13-32-18/h2-6,11-12,14,25H,7-10,13H2,1H3 LEKCAWLPDVDUQR-UHFFFAOYSA-N 235376 US10085990, Example 108::US9393245, 108 Tumor necrosis factor Homo sapiens 450 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235376&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010890 340095043 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409986 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(C)(=O)=O)c(=O)n(-c2ccc3OCOc3c2)c1=O InChI=1S/C25H24N4O7S/c1-34-20-5-3-4-17-22(20)26-13-18-23(17)28(15-8-10-27(11-9-15)37(2,32)33)25(31)29(24(18)30)16-6-7-19-21(12-16)36-14-35-19/h3-7,12-13,15H,8-11,14H2,1-2H3 UFKSSXQQJYIWAM-UHFFFAOYSA-N 235377 US10085990, Example 109::US9393245, 109 Tumor necrosis factor Homo sapiens 8 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235377&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010891 340095044 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409987 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cccc(c2)C#N)c1=O InChI=1S/C24H20N4O3/c1-31-20-11-5-10-18-21(20)26-14-19-22(18)27(16-7-2-3-8-16)24(30)28(23(19)29)17-9-4-6-15(12-17)13-25/h4-6,9-12,14,16H,2-3,7-8H2,1H3 RQVALWJXDPCRBH-UHFFFAOYSA-N 235378 US10085990, Example 110::US9393245, 110 Tumor necrosis factor Homo sapiens 123 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235378 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235378&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 74944950 340095045 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409988 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cccc(SC)c2)c1=O InChI=1S/C24H23N3O3S/c1-30-20-12-6-11-18-21(20)25-14-19-22(18)26(15-7-3-4-8-15)24(29)27(23(19)28)16-9-5-10-17(13-16)31-2/h5-6,9-15H,3-4,7-8H2,1-2H3 ZWHJGDGKNAKKAK-UHFFFAOYSA-N 235379 US10085990, Example 111::US9393245, 111 Tumor necrosis factor Homo sapiens 74 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235379&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 74944951 340095046 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409989 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cccc(c2)S(C)(=O)=O)c1=O InChI=1S/C24H23N3O5S/c1-32-20-12-6-11-18-21(20)25-14-19-22(18)26(15-7-3-4-8-15)24(29)27(23(19)28)16-9-5-10-17(13-16)33(2,30)31/h5-6,9-15H,3-4,7-8H2,1-2H3 LTRCCXKUSQMIAV-UHFFFAOYSA-N 235380 US10085990, Example 112::US9393245, 112 Tumor necrosis factor Homo sapiens 280 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235380 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235380&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010892 340095047 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409990 COc1cccc2c1ncc1c2n([C@@H]2CCN(C2)C(=O)OC(C)(C)C)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C27H27ClN4O5/c1-27(2,3)37-26(35)30-12-11-18(15-30)31-23-19-9-6-10-21(36-4)22(19)29-14-20(23)24(33)32(25(31)34)17-8-5-7-16(28)13-17/h5-10,13-14,18H,11-12,15H2,1-4H3/t18-/m1/s1 CTKRVYLHFHYHOK-GOSISDBHSA-N 235381 BDBM287835::US9393245, 113 Tumor necrosis factor Homo sapiens 0.3 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235381 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235381&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 134686717 375077316 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409991 COc1cccc2c1ncc1c2n([C@@H]2CCNC2)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C22H19ClN4O3/c1-30-18-7-3-6-16-19(18)25-12-17-20(16)26(15-8-9-24-11-15)22(29)27(21(17)28)14-5-2-4-13(23)10-14/h2-7,10,12,15,24H,8-9,11H2,1H3/t15-/m1/s1 PEPXWYFVYAYCEQ-OAHLLOKOSA-N 235382 US10085990, Example 114::US9393245, 114 Tumor necrosis factor Homo sapiens 31 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235382 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235382&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010893 340095048 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409992 COc1cccc2c1ncc1c2n([C@@H]2CCN(C2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C23H21ClN4O5S/c1-33-19-8-4-7-17-20(19)25-12-18-21(17)27(16-9-10-26(13-16)34(2,31)32)23(30)28(22(18)29)15-6-3-5-14(24)11-15/h3-8,11-12,16H,9-10,13H2,1-2H3/t16-/m1/s1 QBTZSDNOQVLDBB-MRXNPFEDSA-N 135820 US10085990, Example 115::US10568888, Example 115::US8853226, 115::US9393245, 115::US9833457, 115 Tumor necrosis factor Homo sapiens 29 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135820 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135820&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 91618206 249493588 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409993 COc1cccc2c1ncc1c2n([C@H]2CCN(C2)C(=O)OC(C)(C)C)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C27H27ClN4O5/c1-27(2,3)37-26(35)30-12-11-18(15-30)31-23-19-9-6-10-21(36-4)22(19)29-14-20(23)24(33)32(25(31)34)17-8-5-7-16(28)13-17/h5-10,13-14,18H,11-12,15H2,1-4H3/t18-/m0/s1 CTKRVYLHFHYHOK-SFHVURJKSA-N 235383 US10085990, Example 116::US9393245, 116 Tumor necrosis factor Homo sapiens 2 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235383 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235383&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010894 340095049 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409994 COc1cccc2c1ncc1c2n([C@H]2CCNC2)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C22H19ClN4O3/c1-30-18-7-3-6-16-19(18)25-12-17-20(16)26(15-8-9-24-11-15)22(29)27(21(17)28)14-5-2-4-13(23)10-14/h2-7,10,12,15,24H,8-9,11H2,1H3/t15-/m0/s1 PEPXWYFVYAYCEQ-HNNXBMFYSA-N 235384 US10085990, Example 117::US9393245, 117 Tumor necrosis factor Homo sapiens 1000 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235384 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235384&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 129010895 340095050 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409995 COc1cccc2c1ncc1c2n([C@H]2CCN(C2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C23H21ClN4O5S/c1-33-19-8-4-7-17-20(19)25-12-18-21(17)27(16-9-10-26(13-16)34(2,31)32)23(30)28(22(18)29)15-6-3-5-14(24)11-15/h3-8,11-12,16H,9-10,13H2,1-2H3/t16-/m0/s1 QBTZSDNOQVLDBB-INIZCTEOSA-N 135821 US10085990, Example 118::US10568888, Example 118::US8853226, 118::US9393245, 118::US9833457, 118 Tumor necrosis factor Homo sapiens 29 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135821&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 91618207 249493589 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409996 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2ccc3OCCOc3c2)c1=O InChI=1S/C25H23N3O5/c1-31-20-8-4-7-17-22(20)26-14-18-23(17)27(15-5-2-3-6-15)25(30)28(24(18)29)16-9-10-19-21(13-16)33-12-11-32-19/h4,7-10,13-15H,2-3,5-6,11-12H2,1H3 FUOSKBKPXMUPKQ-UHFFFAOYSA-N 235386 US10085990, Example 120::US9393245, 120 Tumor necrosis factor Homo sapiens 240 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235386 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235386&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762330 340095051 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409997 COC(=O)N1CCC(CC1)n1c2c3cccc(OC)c3ncc2c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H23ClN4O5/c1-34-20-8-4-7-18-21(20)27-14-19-22(18)29(16-9-11-28(12-10-16)25(33)35-2)24(32)30(23(19)31)17-6-3-5-15(26)13-17/h3-8,13-14,16H,9-12H2,1-2H3 NZIWLTJRFGAVRA-UHFFFAOYSA-N 235388 US10085990, Example 124::US9393245, 124 Tumor necrosis factor Homo sapiens 50000 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235388 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235388&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762241 340095052 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409998 COc1cccc2c1ncc1c2n(CC2CCN(CC2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H25ClN4O5S/c1-35-21-8-4-7-19-22(21)27-14-20-23(19)29(15-16-9-11-28(12-10-16)36(2,33)34)25(32)30(24(20)31)18-6-3-5-17(26)13-18/h3-8,13-14,16H,9-12,15H2,1-2H3 PYZDPPRYPHIHCL-UHFFFAOYSA-N 235390 US10085990, Example 126::US9393245, 126 Tumor necrosis factor Homo sapiens 2 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235390&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 76762320 340095053 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 409999 COc1cccc2c1ncc1c2n(C2CC[C@@H](CC2)NS(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H25ClN4O5S/c1-35-21-8-4-7-19-22(21)27-14-20-23(19)29(17-11-9-16(10-12-17)28-36(2,33)34)25(32)30(24(20)31)18-6-3-5-15(26)13-18/h3-8,13-14,16-17,28H,9-12H2,1-2H3/t16-,17? QMGJUCFLYMBHRX-XPIKVJKASA-N 135824 US10085990, Example 127::US10568888, Example 127::US8853226, 127::US9393245, 127::US9833457, 127 Tumor necrosis factor Homo sapiens 6 25.00 C US Patent 10.7270/Q2JH3K2T aid1803027 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135824 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135824&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 72279277 249493592 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 410000 CCn1c(=O)n(C2CCCC2)c2c3cccc(Cl)c3ncc2c1=O InChI=1S/C18H18ClN3O2/c1-2-21-17(23)13-10-20-15-12(8-5-9-14(15)19)16(13)22(18(21)24)11-6-3-4-7-11/h5,8-11H,2-4,6-7H2,1H3 RNTPXDNXVJTNNP-UHFFFAOYSA-N 135812 US10085990, Example 30::US10568888, Example 30::US8853226, 30::US9393245, 30::US9833457, 30 Isoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2) Human 17000 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135812 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10118&target=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135812&enzyme=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search 76762338 249493580 1 MKEHGGTFSSTGISGGSGDSAMDSLQPLQPNYMPVCLFAEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 410001 CCCc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(CC)c1=O InChI=1S/C21H25N3O2/c1-3-8-14-9-7-12-16-18(14)22-13-17-19(16)24(15-10-5-6-11-15)21(26)23(4-2)20(17)25/h7,9,12-13,15H,3-6,8,10-11H2,1-2H3 IAIFPELWEXGBKC-UHFFFAOYSA-N 135813 US10085990, Example 32::US10568888, Example 32::US8853226, 32::US9393245, 32::US9833457, 32 Isoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2) Human 25000 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135813 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10118&target=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135813&enzyme=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search 76762254 249493581 1 MKEHGGTFSSTGISGGSGDSAMDSLQPLQPNYMPVCLFAEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 410002 CCn1c(=O)n(C2CCCC2)c2c3cccc(C(C)C)c3ncc2c1=O InChI=1S/C21H25N3O2/c1-4-23-20(25)17-12-22-18-15(13(2)3)10-7-11-16(18)19(17)24(21(23)26)14-8-5-6-9-14/h7,10-14H,4-6,8-9H2,1-3H3 IWWGJHDCEUWDTE-UHFFFAOYSA-N 135814 US10085990, Example 33::US10568888, Example 33::US8853226, 33::US9393245, 33::US9833457, 33 Isoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2) Human 12400 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10118&target=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135814&enzyme=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search 76762293 249493582 1 MKEHGGTFSSTGISGGSGDSAMDSLQPLQPNYMPVCLFAEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 410003 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cc(C)cs2)c1=O InChI=1S/C22H21N3O3S/c1-13-10-18(29-12-13)25-21(26)16-11-23-19-15(8-5-9-17(19)28-2)20(16)24(22(25)27)14-6-3-4-7-14/h5,8-12,14H,3-4,6-7H2,1-2H3 XBMCCMKXNQMPDO-UHFFFAOYSA-N 135815 US10085990, Example 51::US10568888, Example 51::US8853226, 51::US9393245, 51::US9833457, 51 Isoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2) Human 126 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135815 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10118&target=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135815&enzyme=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search 91618205 249493583 1 MKEHGGTFSSTGISGGSGDSAMDSLQPLQPNYMPVCLFAEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 410004 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cccc(C)c2)c1=O InChI=1S/C24H23N3O3/c1-15-7-5-10-17(13-15)27-23(28)19-14-25-21-18(11-6-12-20(21)30-2)22(19)26(24(27)29)16-8-3-4-9-16/h5-7,10-14,16H,3-4,8-9H2,1-2H3 NMCBQDCTQPGXHQ-UHFFFAOYSA-N 135816 US10085990, Example 54::US10568888, Example 54::US8853226, 54::US9393245, 54::US9833457, 54 Isoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2) Human 78 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135816 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10118&target=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135816&enzyme=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search 76762299 249493584 1 MKEHGGTFSSTGISGGSGDSAMDSLQPLQPNYMPVCLFAEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 410005 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2ccc3OCOc3c2)c1=O InChI=1S/C24H21N3O5/c1-30-19-8-4-7-16-21(19)25-12-17-22(16)26(14-5-2-3-6-14)24(29)27(23(17)28)15-9-10-18-20(11-15)32-13-31-18/h4,7-12,14H,2-3,5-6,13H2,1H3 JMKXHWHMULJLQG-UHFFFAOYSA-N 135817 US10085990, Example 84::US10568888, Example 84::US8853226, 84::US9393245, 84::US9833457, 84 Isoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2) Human 513 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135817 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10118&target=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135817&enzyme=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search 74944884 249493585 1 MKEHGGTFSSTGISGGSGDSAMDSLQPLQPNYMPVCLFAEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 410006 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C24H23ClN4O5S/c1-34-20-8-4-7-18-21(20)26-14-19-22(18)28(16-9-11-27(12-10-16)35(2,32)33)24(31)29(23(19)30)17-6-3-5-15(25)13-17/h3-8,13-14,16H,9-12H2,1-2H3 MUQKVPSLHRVESB-UHFFFAOYSA-N 135818 US10085990, Example 92::US10568888, Example 92::US8853226, 92::US9393245, 92::US9833457, 92 Isoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2) Human 68 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135818 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10118&target=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135818&enzyme=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search 74944887 249493586 1 MKEHGGTFSSTGISGGSGDSAMDSLQPLQPNYMPVCLFAEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 410007 COc1cccc2c1ncc1c2n(C2CC[C@@H](CC2)C(O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H22ClN3O5/c1-34-20-7-3-6-18-21(20)27-13-19-22(18)28(16-10-8-14(9-11-16)24(31)32)25(33)29(23(19)30)17-5-2-4-15(26)12-17/h2-7,12-14,16H,8-11H2,1H3,(H,31,32)/t14-,16? VLSIAPYZDCCBPU-GBANJREWSA-N 135819 US10085990, Example 103::US10568888, Example 103::US8853226, 103::US9393245, 103 Isoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2) Human 17 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135819 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10118&target=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135819&enzyme=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search 74931538 249493587 1 MKEHGGTFSSTGISGGSGDSAMDSLQPLQPNYMPVCLFAEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 410008 COc1cccc2c1ncc1c2n([C@@H]2CCN(C2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C23H21ClN4O5S/c1-33-19-8-4-7-17-20(19)25-12-18-21(17)27(16-9-10-26(13-16)34(2,31)32)23(30)28(22(18)29)15-6-3-5-14(24)11-15/h3-8,11-12,16H,9-10,13H2,1-2H3/t16-/m1/s1 QBTZSDNOQVLDBB-MRXNPFEDSA-N 135820 US10085990, Example 115::US10568888, Example 115::US8853226, 115::US9393245, 115::US9833457, 115 Isoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2) Human 49 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135820 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10118&target=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135820&enzyme=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search 91618206 249493588 1 MKEHGGTFSSTGISGGSGDSAMDSLQPLQPNYMPVCLFAEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 410009 COc1cccc2c1ncc1c2n([C@H]2CCN(C2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C23H21ClN4O5S/c1-33-19-8-4-7-17-20(19)25-12-18-21(17)27(16-9-10-26(13-16)34(2,31)32)23(30)28(22(18)29)15-6-3-5-14(24)11-15/h3-8,11-12,16H,9-10,13H2,1-2H3/t16-/m0/s1 QBTZSDNOQVLDBB-INIZCTEOSA-N 135821 US10085990, Example 118::US10568888, Example 118::US8853226, 118::US9393245, 118::US9833457, 118 Isoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2) Human 80 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10118&target=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135821&enzyme=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search 91618207 249493589 1 MKEHGGTFSSTGISGGSGDSAMDSLQPLQPNYMPVCLFAEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 410010 CCS(=O)(=O)N1CCC(CC1)n1c2c3cccc(OC)c3ncc2c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H25ClN4O5S/c1-3-36(33,34)28-12-10-17(11-13-28)29-23-19-8-5-9-21(35-2)22(19)27-15-20(23)24(31)30(25(29)32)18-7-4-6-16(26)14-18/h4-9,14-15,17H,3,10-13H2,1-2H3 IISWCMIDUMTUPJ-UHFFFAOYSA-N 135822 US10085990, Example 121::US10568888, Example 121::US8853226, 121::US9393245, 121::US9833457, 121 Isoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2) Human 26 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135822 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10118&target=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135822&enzyme=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search 76762313 249493590 1 MKEHGGTFSSTGISGGSGDSAMDSLQPLQPNYMPVCLFAEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 410011 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(=O)(=O)CS(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H25ClN4O7S2/c1-37-21-8-4-7-19-22(21)27-14-20-23(19)29(25(32)30(24(20)31)18-6-3-5-16(26)13-18)17-9-11-28(12-10-17)39(35,36)15-38(2,33)34/h3-8,13-14,17H,9-12,15H2,1-2H3 SMPOHPYMVGJQOO-UHFFFAOYSA-N 135823 US10085990, Example 122::US10568888, Example 122::US8853226, 122::US9393245, 122::US9833457, 122 Isoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2) Human 39 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135823 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10118&target=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135823&enzyme=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search 76762332 249493591 1 MKEHGGTFSSTGISGGSGDSAMDSLQPLQPNYMPVCLFAEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 410012 COc1cccc2c1ncc1c2n(C2CC[C@@H](CC2)NS(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H25ClN4O5S/c1-35-21-8-4-7-19-22(21)27-14-20-23(19)29(17-11-9-16(10-12-17)28-36(2,33)34)25(32)30(24(20)31)18-6-3-5-15(26)13-18/h3-8,13-14,16-17,28H,9-12H2,1-2H3/t16-,17? QMGJUCFLYMBHRX-XPIKVJKASA-N 135824 US10085990, Example 127::US10568888, Example 127::US8853226, 127::US9393245, 127::US9833457, 127 Isoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B2) Human 25 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135824 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10118&target=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135824&enzyme=Isoform+PDE4B2+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B+%28PDE4B2%29&column=ki&startPg=0&Increment=50&submit=Search 72279277 249493592 1 MKEHGGTFSSTGISGGSGDSAMDSLQPLQPNYMPVCLFAEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 1TB5,2QYL,3O0J,3W5E,3WD9,4KP6,4MYQ,4NW7,5K6J cAMP-specific 3',5'-cyclic phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 410013 CCn1c(=O)n(C2CCCC2)c2c3cccc(Cl)c3ncc2c1=O InChI=1S/C18H18ClN3O2/c1-2-21-17(23)13-10-20-15-12(8-5-9-14(15)19)16(13)22(18(21)24)11-6-3-4-7-11/h5,8-11H,2-4,6-7H2,1H3 RNTPXDNXVJTNNP-UHFFFAOYSA-N 135812 US10085990, Example 30::US10568888, Example 30::US8853226, 30::US9393245, 30::US9833457, 30 Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) Human 25000 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135812 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10119&target=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135812&enzyme=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search 76762338 249493580 1 MSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 410014 CCCc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(CC)c1=O InChI=1S/C21H25N3O2/c1-3-8-14-9-7-12-16-18(14)22-13-17-19(16)24(15-10-5-6-11-15)21(26)23(4-2)20(17)25/h7,9,12-13,15H,3-6,8,10-11H2,1-2H3 IAIFPELWEXGBKC-UHFFFAOYSA-N 135813 US10085990, Example 32::US10568888, Example 32::US8853226, 32::US9393245, 32::US9833457, 32 Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) Human 25000 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135813 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10119&target=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135813&enzyme=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search 76762254 249493581 1 MSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 410015 CCn1c(=O)n(C2CCCC2)c2c3cccc(C(C)C)c3ncc2c1=O InChI=1S/C21H25N3O2/c1-4-23-20(25)17-12-22-18-15(13(2)3)10-7-11-16(18)19(17)24(21(23)26)14-8-5-6-9-14/h7,10-14H,4-6,8-9H2,1-3H3 IWWGJHDCEUWDTE-UHFFFAOYSA-N 135814 US10085990, Example 33::US10568888, Example 33::US8853226, 33::US9393245, 33::US9833457, 33 Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) Human 25000 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10119&target=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135814&enzyme=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search 76762293 249493582 1 MSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 410016 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cc(C)cs2)c1=O InChI=1S/C22H21N3O3S/c1-13-10-18(29-12-13)25-21(26)16-11-23-19-15(8-5-9-17(19)28-2)20(16)24(22(25)27)14-6-3-4-7-14/h5,8-12,14H,3-4,6-7H2,1-2H3 XBMCCMKXNQMPDO-UHFFFAOYSA-N 135815 US10085990, Example 51::US10568888, Example 51::US8853226, 51::US9393245, 51::US9833457, 51 Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) Human 616 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135815 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10119&target=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135815&enzyme=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search 91618205 249493583 1 MSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 410017 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cccc(C)c2)c1=O InChI=1S/C24H23N3O3/c1-15-7-5-10-17(13-15)27-23(28)19-14-25-21-18(11-6-12-20(21)30-2)22(19)26(24(27)29)16-8-3-4-9-16/h5-7,10-14,16H,3-4,8-9H2,1-2H3 NMCBQDCTQPGXHQ-UHFFFAOYSA-N 135816 US10085990, Example 54::US10568888, Example 54::US8853226, 54::US9393245, 54::US9833457, 54 Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) Human 338 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135816 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10119&target=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135816&enzyme=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search 76762299 249493584 1 MSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 410018 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2ccc3OCOc3c2)c1=O InChI=1S/C24H21N3O5/c1-30-19-8-4-7-16-21(19)25-12-17-22(16)26(14-5-2-3-6-14)24(29)27(23(17)28)15-9-10-18-20(11-15)32-13-31-18/h4,7-12,14H,2-3,5-6,13H2,1H3 JMKXHWHMULJLQG-UHFFFAOYSA-N 135817 US10085990, Example 84::US10568888, Example 84::US8853226, 84::US9393245, 84::US9833457, 84 Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) Human 827 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135817 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10119&target=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135817&enzyme=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search 74944884 249493585 1 MSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 410019 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C24H23ClN4O5S/c1-34-20-8-4-7-18-21(20)26-14-19-22(18)28(16-9-11-27(12-10-16)35(2,32)33)24(31)29(23(19)30)17-6-3-5-15(25)13-17/h3-8,13-14,16H,9-12H2,1-2H3 MUQKVPSLHRVESB-UHFFFAOYSA-N 135818 US10085990, Example 92::US10568888, Example 92::US8853226, 92::US9393245, 92::US9833457, 92 Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) Human 151 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135818 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10119&target=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135818&enzyme=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search 74944887 249493586 1 MSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 410020 COc1cccc2c1ncc1c2n(C2CC[C@@H](CC2)C(O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H22ClN3O5/c1-34-20-7-3-6-18-21(20)27-13-19-22(18)28(16-10-8-14(9-11-16)24(31)32)25(33)29(23(19)30)17-5-2-4-15(26)12-17/h2-7,12-14,16H,8-11H2,1H3,(H,31,32)/t14-,16? VLSIAPYZDCCBPU-GBANJREWSA-N 135819 US10085990, Example 103::US10568888, Example 103::US8853226, 103::US9393245, 103 Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) Human 55 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135819 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10119&target=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135819&enzyme=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search 74931538 249493587 1 MSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 410021 COc1cccc2c1ncc1c2n([C@@H]2CCN(C2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C23H21ClN4O5S/c1-33-19-8-4-7-17-20(19)25-12-18-21(17)27(16-9-10-26(13-16)34(2,31)32)23(30)28(22(18)29)15-6-3-5-14(24)11-15/h3-8,11-12,16H,9-10,13H2,1-2H3/t16-/m1/s1 QBTZSDNOQVLDBB-MRXNPFEDSA-N 135820 US10085990, Example 115::US10568888, Example 115::US8853226, 115::US9393245, 115::US9833457, 115 Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) Human 163 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135820 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10119&target=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135820&enzyme=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search 91618206 249493588 1 MSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 410022 COc1cccc2c1ncc1c2n([C@H]2CCN(C2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C23H21ClN4O5S/c1-33-19-8-4-7-17-20(19)25-12-18-21(17)27(16-9-10-26(13-16)34(2,31)32)23(30)28(22(18)29)15-6-3-5-14(24)11-15/h3-8,11-12,16H,9-10,13H2,1-2H3/t16-/m0/s1 QBTZSDNOQVLDBB-INIZCTEOSA-N 135821 US10085990, Example 118::US10568888, Example 118::US8853226, 118::US9393245, 118::US9833457, 118 Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) Human 206 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10119&target=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135821&enzyme=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search 91618207 249493589 1 MSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 410023 CCS(=O)(=O)N1CCC(CC1)n1c2c3cccc(OC)c3ncc2c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H25ClN4O5S/c1-3-36(33,34)28-12-10-17(11-13-28)29-23-19-8-5-9-21(35-2)22(19)27-15-20(23)24(31)30(25(29)32)18-7-4-6-16(26)14-18/h4-9,14-15,17H,3,10-13H2,1-2H3 IISWCMIDUMTUPJ-UHFFFAOYSA-N 135822 US10085990, Example 121::US10568888, Example 121::US8853226, 121::US9393245, 121::US9833457, 121 Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) Human 59 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135822 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10119&target=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135822&enzyme=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search 76762313 249493590 1 MSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 410024 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(=O)(=O)CS(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H25ClN4O7S2/c1-37-21-8-4-7-19-22(21)27-14-20-23(19)29(25(32)30(24(20)31)18-6-3-5-16(26)13-18)17-9-11-28(12-10-17)39(35,36)15-38(2,33)34/h3-8,13-14,17H,9-12,15H2,1-2H3 SMPOHPYMVGJQOO-UHFFFAOYSA-N 135823 US10085990, Example 122::US10568888, Example 122::US8853226, 122::US9393245, 122::US9833457, 122 Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) Human 80 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135823 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10119&target=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135823&enzyme=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search 76762332 249493591 1 MSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 410025 COc1cccc2c1ncc1c2n(C2CC[C@@H](CC2)NS(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H25ClN4O5S/c1-35-21-8-4-7-19-22(21)27-14-20-23(19)29(17-11-9-16(10-12-17)28-36(2,33)34)25(32)30(24(20)31)18-6-3-5-15(26)13-18/h3-8,13-14,16-17,28H,9-12H2,1-2H3/t16-,17? QMGJUCFLYMBHRX-XPIKVJKASA-N 135824 US10085990, Example 127::US10568888, Example 127::US8853226, 127::US9393245, 127::US9833457, 127 Isoform 10 of cAMP-specific 3',5'-cyclic phosphodiesterase 4D (10) Human 73 30.00 C US Patent 10.7270/Q2JH3K2T aid1803026 US9393245 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 7/19/2016 6/26/2017 vTv Therapeutics LLC http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135824 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10119&target=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135824&enzyme=Isoform+10+of+cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D+%2810%29&column=ki&startPg=0&Increment=50&submit=Search 72279277 249493592 1 MSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 1OYN,1PTW,1Q9M,1TB7,1TBB,1XOM,1XON,1XOQ,1XOR,1Y2B,1Y2C,1Y2D,1Y2E,1Y2K,1ZKN,2FM0,2FM5,2QYN,3IAK,3K4S,3O0J,3SL3,3SL4,3SL6,3SL8,3V9B,4MYQ,4NW7,4OGB,4W1O,4WCU,5K1I,5K32,5K6J,5LBO,5WH5,5WH6,5WQA,6AKR,6FDI,6FE7,6FEB,6FET,6FT0,6FTA,6FTW,6FW3,6HWO,6IAG,6IBF,6IM6,6IMB,6IMD,6IMI,6IMO,6IMR,6IMT,6IND,6INK,6INM,6KJZ,6KK0,6LRM,6RCW,7A8Q,7A9V,7AAG,7AB9,7ABD,7ABE,7ABJ,7CBJ,7CBQ,7F2K,7F2L,7F2M,7XAA,7XAB,7XBB,7YQF,7YSX cAMP-specific 3',5'-cyclic phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7